Aldeyra Therapeutics Inc (NASDAQ: ALDX) kicked off on Monday, up 9.38% from the previous trading day, before settling in for the closing price of $4.69. Over the past 52 weeks, ALDX has traded in a range of $1.14-$7.20.
During the last 5-year period, the sales growth of Healthcare Sector giant was 15.99%. While this was happening, its average annual earnings per share was recorded 17.66%. With a float of $58.21 million, this company’s outstanding shares have now reached $60.16 million.
Aldeyra Therapeutics Inc (ALDX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Aldeyra Therapeutics Inc is 3.25%, while institutional ownership is 57.72%. The most recent insider transaction that took place on Aug 13 ’25, was worth 13,250. In this transaction Principal Financial Officer of this company bought 2,500 shares at a rate of $5.30, taking the stock ownership to the 2,500 shares. Before that another transaction happened on Aug 11 ’25, when Company’s Chief Development Officer sold 22,073 for $5.15, making the entire transaction worth $113,713. This insider now owns 221,799 shares in total.
Aldeyra Therapeutics Inc (ALDX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.27 earnings per share (EPS), lower than consensus estimate (set at -0.22) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Trading Performance Indicators
Take a look at Aldeyra Therapeutics Inc’s (ALDX) current performance indicators. Last quarter, stock had a quick ratio of 2.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.72, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach 0.15 in one year’s time.
Technical Analysis of Aldeyra Therapeutics Inc (ALDX)
Looking closely at Aldeyra Therapeutics Inc (NASDAQ: ALDX), its last 5-days average volume was 0.66 million, which is a drop from its year-to-date volume of 1.07 million. As of the previous 9 days, the stock’s Stochastic %D was 39.13%.
During the past 100 days, Aldeyra Therapeutics Inc’s (ALDX) raw stochastic average was set at 67.60%, which indicates a significant increase from 60.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.28 in the past 14 days, which was lower than the 0.29 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.28, while its 200-day Moving Average is $4.63. However, in the short run, Aldeyra Therapeutics Inc’s stock first resistance to watch stands at $5.28. Second resistance stands at $5.44. The third major resistance level sits at $5.72. If the price goes on to break the first support level at $4.84, it is likely to go to the next support level at $4.56. Now, if the price goes above the second support level, the third support stands at $4.40.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Key Stats
The company with the Market Capitalisation of 308.63 million has total of 60,163K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -55,850 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -9,770 K.
